Showing 145,821 - 145,840 results of 229,666 for search '(( 5 ((wt decrease) OR (nn decrease)) ) OR ( 10 ((we decrease) OR (a decrease)) ))', query time: 2.30s Refine Results
  1. 145821
  2. 145822
  3. 145823
  4. 145824
  5. 145825
  6. 145826
  7. 145827
  8. 145828
  9. 145829
  10. 145830
  11. 145831
  12. 145832
  13. 145833
  14. 145834
  15. 145835
  16. 145836

    Ets-1 Activity Is Required for Cranial but not Trunk Delamination. by Eric Théveneau (66022)

    Published 2013
    “…Expression of <i>c-ets-1 DBD</i> in the head leads to a decrease or a lack of <i>ap-2</i> (B–D, H–J) and HNK-1 expression (E, K). …”
  17. 145837
  18. 145838

    Supplementary file 1_Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells.jpeg by Donatella Treppiedi (10146335)

    Published 2025
    “…Interestingly, cells incubation with the recombinant VEGF164a protein impaired the decrease of cell migration and cell viability mediated by both SRPK1 inhibitors. …”
  19. 145839

    Data Sheet 1_Exploring the glucose-lowering and anti-inflammatory immune mechanism of artemether by AMPK/mTOR pathway and microbiome based on multi-omics.docx by Tao Jiang (28401)

    Published 2025
    “…The elevation of SCFAs, especially propionic acid, may activate the AMPK/mTOR pathway, leading to a decrease in the levels of TNF-α, IL-1β, IL-6, NF-κB, and IL-17A, while increasing the levels of IL-10, thereby alleviating the inflammatory state and improving glucolipid metabolic disorder in T2DM. …”
  20. 145840

    Image 1_Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells.jpg by Donatella Treppiedi (10146335)

    Published 2025
    “…Interestingly, cells incubation with the recombinant VEGF164a protein impaired the decrease of cell migration and cell viability mediated by both SRPK1 inhibitors. …”